Clinical Trials Logo

Clinical Trial Summary

A prospective randomized study designed to compare the efficacy of transcervical vasopressin injection versus vaginal misoprostol in reducing intra -operative blood loss during hysteroscopic mymectomy .


Clinical Trial Description

This was a prospective, randomized, study on forty women with symptomatic submucous myoma presented mostly with bleeding and/or infertility scheduled for hysteroscopic myomectomy were randomized to groups (group A) 20 patients transcervical intramyoma vasopressin injection and (group B) 20patients with vaginal misoprostol is used . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03930069
Study type Interventional
Source Zagazig University
Contact
Status Completed
Phase Phase 2/Phase 3
Start date May 2, 2016
Completion date March 15, 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05898321 - To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone N/A